Utility of F-18-FDG PET/CT for staging NK/T-cell lymphomas

作者:Wu, Hu Bing; Wang, Quan Shi*; Wang, Ming Fang; Li, Hong Sheng; Zhou, Wen Lan; Ye, Xiang Hua; Wang, Qiao Yu
来源:Nuclear Medicine Communications, 2010, 31(3): 195-200.
DOI:10.1097/MNM.0b013e32833310fa

摘要

Purpose Extranodal natural killer (NK)/T-cell lymphoma is a rare neoplasm and limited data has reported regarding the utilization of fluorine-18, fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) in this disease. The aim of this study was to assess the role of F-18-FDG PET/CT in the staging of NK/T-cell lymphomas. Patients and methods Thirteen newly diagnosed and two recurrent patients with NK/T-cell lymphoma who received F-18-FDG PET/CT were studied. The lesion with intense F-18-FDG uptake was suggested as the positive and was measured using maximal standardized uptake values. The results of PET/CT were compared with the conventional staging examinations. Results F-18-FDG PET/CT detected nasal or extranasal lymphoma lesions in at least one site in all of the 15 patients. There was no significant difference of F-18-FDG uptake in lesions between patients with stage I-II disease and those with stage III-IV disease (maximal standardized uptake values 8.44 /- 5.56 vs. 10.32 /- 7.80; t = 0.757, P > 0.05). In two patients with an indeterminate diagnosis, the diagnosis of NK/T-cell lymphomas was established by biopsy guided by PET/CT and the status of stage IV was correctly identified. In 13 patients with definite diagnosis, the stage of disease was changed in six patients on the basis of F-18-FDG PET/CT. Two patients were down staged, and four patients upstaged. Conclusion The lesions of the NK/T-cell lymphoma are F-18-FDG avid and PET/CT seems to be useful in the staging of this disease.